PDB21 COST-EFFECTIVENESS OF INSULIN GLARGINE PLUS ORAL ANTIDIABETIC DRUGS (OADS) COMPARED TO PREMIXED INSULIN FOR TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS IN THE CANADIAN PAYER SETTING
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66668-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)66668-5/fulltext
Section Title :
Section Order :
504
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66668-5&doi=10.1016/S1098-3015(10)66668-5